Loading...
*  Amyloid-based Therapies for Alzheimer's Disease: From Vaccines to Secretase Inhibitors « Hacked by 4Ri3 60ndr0n9
Amyloid-based Therapies for Alzheimer's Disease: From Vaccines to Secretase Inhibitors. Primary Psychiatry , June 1, 2009. ... The Place of Amyloid in Alzheimer Disease. The ultimate diagnosis of Alzheimer's disease is based on neuropathologic criteria, ... The uncertain role of amyloid in common, late-onset Alzheimer's disease is highlighted by reports of the presence of amyloid in ... Given that the amyloid clearance induced by the AN1792 vaccine was felt to be due to antibody-based immunity while the cases of ...
  http://primarypsychiatry.com/amyloid-based-therapies-for-alzheimeras-disease-from-vaccines-to-secretase-inhibitors/
*  Polypeptide conjugates comprising a β-amyloid plaque-specific epitope as new vaccine structures against Alzheimer's disease
... * ... Polypeptide conjugates comprising a β-amyloid plaque-specific epitope as new vaccine structures against Alzheimer's disease. ... Polypeptide conjugates comprising a β-amyloid plaque-specific epitope as new vaccine structures against Alzheimer's disease. In ... Polypeptide conjugates comprising a β-amyloid plaque-specific epitope as new vaccine structures against Alzheimer's disease}, ...
  https://kops.uni-konstanz.de/handle/123456789/17566
*  European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients - Full Text View - ClinicalTrials.gov
Previous use of anti-amyloid or vaccine treatment for Alzheimer's disease.. *Use of an investigational drug within 30 days ... MedlinePlus related topics: Alzheimer's Disease Genetic and Rare Diseases Information Center resources: Familial Alzheimer ... European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients. The safety and scientific validity of this study is ... A Phase III Study of the Efficacy and Safety of 3APS as Add-on Therapy in Mild to Moderate Alzheimer's Disease. ...
  https://clinicaltrials.gov/ct2/show/study/NCT00217763?view=record
*  European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients - Tabular View - ClinicalTrials.gov
Previous use of anti-amyloid or vaccine treatment for Alzheimer's disease.. *Use of an investigational drug within 30 days ... European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients. The safety and scientific validity of this study is ... European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients. Official Title ICMJE A Phase III Study of the Efficacy ... Diagnosis of probable Alzheimer's disease based on the National Institute of Neurological and Communicative Disorders and ...
  https://clinicaltrials.gov/ct2/show/record/NCT00217763
*  Genetically modified tomato - Wikipedia
"Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer's disease". Biotechnology letters. 30 ... Korean scientists are looking at using the tomato to express a vaccine against Alzheimer's disease.[42] Hilary Koprowski, who ... Vaccines[edit]. Tomatoes (along with potatoes, bananas and other plants) are being investigated as vehicles for delivering ... Goyal, R.; Ramachandran, R.; Goyal, P.; Sharma, V. (2007). "Edible vaccines: Current status and future". Indian Journal of ...
  https://en.wikipedia.org/wiki/Fish_tomato
*  OnCall+ Alzheimer's Contributors - ABC News
Clinical trials of the newest and most promising Alzheimer's drugs including amyloid vaccines and anti-amyloid drugs. ... called amyloid, inside and outside nerve cells. - New imaging chemicals permit scientists to see Alzheimer's amyloid pathology ... Use of new transgenic mice and new imaging chemicals to screen for new Alzheimer's drugs that reduce amyloid buildup, including ... OnCall+ Alzheimer's Contributor. Mary Sano, Ph.D., Director, Alzheimer's Disease Research Center, Mount Sinai School of ...
  http://abcnews.go.com/Health/AlzheimersQuestions/story?id=7507542&page=3
*  Alzheimer's Reading Room, The
Here you can read summaries of all the latest updates from Alzheimer's Reading Room, The ... DNA Vaccine Reduces Tau and Beta-Amyloid in Alzheimer's Mice. This study is the culmination of a decade of research that has ... alzheimer's alzheimer's awareness alzheimer's care alzheimer's dying dementia care elder care family caregiving help alzheimer ... Alzheimer research alzheimer's webinar Alzheimers Dementia charity navigator alzheimer's cure alzheimer's cure alzheimer's fund ...
  https://medworm.com/blog/alzheimers-reading-room-the/
*  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel | JEM
Amyloid β peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier. ...
  http://jem.rupress.org/content/202/4/473.full
*  Safety and Tolerability of Etanercept in Alzheimer's Disease - Full Text View - ClinicalTrials.gov
Previous exposure to amyloid vaccines, monoclonal antibodies or intravenous immunoglobulins meant to treat Alzheimer's disease ... Vaccination or immunization with any live vaccine (eg: polio, rubella, yellow fever) or the pneumococcal vaccine within the ... Alzheimer Disease. Dementia. Brain Diseases. Central Nervous System Diseases. Nervous System Diseases. Tauopathies. ... The primary aim of the study is to determine the safety and tolerability of etanercept in subjects with Alzheimer's Disease. ...
  https://clinicaltrials.gov/ct2/show/study/NCT01068353?view=results
*  Early steps toward an Alzheimer's vaccine - Harvard Health Blog - Harvard Health Publishing
Several other Alzheimer's vaccines that target the beta amyloid protein are also being tested in clinical trials. Another ... Some encouraging Alzheimer's news from Sweden: a vaccine called CAD106 appears to be safe and ramps up the body's immune system ... The vaccine is designed to activate the body's immune system against beta amyloid, a protein fragment that forms deposits ... While it's unclear if beta amyloid plaques cause Alzheimer's or are a result of it, scientists do know that the plaques are an ...
  https://www.health.harvard.edu/blog/early-steps-toward-an-alzheimers-vaccine-201206124878
*  WO2005028496A3 - Vaccine for treatment and prevention of herpes simplex virus infection - Google Patents
Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases ... Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases ... WO2005028496A3 - Vaccine for treatment and prevention of herpes simplex virus infection - Google Patents. Vaccine for treatment ... Vaccines based on membrane bound proteins and process for making them US4642333A (en) 1983-09-16. 1987-02-10. Stanley Person. ...
  https://patents.google.com/patent/WO2005028496A3/en
*  Synthetic vaccine - Wikipedia
... amyloid β peptide vaccine for mild Alzheimer's disease". Alzheimer's & Dementia: Translational Research & Clinical ... Article on synthetic Hib vaccine CRISP Thesaurus entry on Synthetic Vaccines Web Health Centre: History of Vaccines. ... a synthetic peptide vaccine targeting amyloid beta, showed that the drug was able to generate antibodies to specific amyloid ... A synthetic vaccine is a vaccine consisting mainly of synthetic peptides, carbohydrates, or antigens. They are usually ...
  https://en.wikipedia.org/wiki/Synthetic_vaccine
*  GSK signs Alzheimer vaccine deal as CHMP recommends Alli - PharmaTimes
GlaxoSmithKline has signed a deal to get exclusive rights to early-stage vaccines for Alzheimer's disease being developed by ... unit has bought the rights to develop and commercialise two Alzheimer's disease vaccine candidates which target beta-amyloid. ... GSK signs Alzheimer vaccine deal as CHMP recommends Alli. 24th October 2008. ... GlaxoSmithKline has signed a deal to get exclusive rights to early-stage vaccines for Alzheimer's disease being developed by ...
  http://www.pharmatimes.com/news/gsk_signs_alzheimer_vaccine_deal_as_chmp_recommends_alli_986529
*  Can Network Analysis Identify Pathological Pathways in Alzheimer's | ALZFORUM
Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based ... Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid β. Neuron. 2013 April 25 online. Read article. ... Last year, two groups uncovered mutations in the gene for TREM2 that multiply a person's risk for Alzheimer's disease about ... Carson: In the standard mouse models of amyloid pathology, both TYROBP (also called DAP12) and TREM2 are upregulated in the ...
  https://www.alzforum.org/webinars/can-network-analysis-identify-pathological-pathways-alzheimers
*  www.bioquicknews.com | BioQuick News--Life Science News from Around the Globe
DNA Vaccine Reduces Both Toxic Proteins (Beta-Amyloid & Tau) Linked to Alzheimer's in Mouse Model. Tue, 11/20/2018 - 10:10 - ... 2018 in Alzheimer's Research and Therapy, demonstrates how a vaccine containing DNA coding for a segment of beta-amyloid also ... A DNA vaccine tested in mice reduces accumulation of both types of toxic proteins associated with Alzheimer's disease, ... which produces the toxic beta amyloid proteins defining Alzheimer's disease, gives rise to novel gene variants in neurons-- ...
  http://www.bioquicknews.com/node?page=1
*  Award-Winning Research Points Toward Targeted Alzheimer s Vaccine
26, 2011 An accomplice to the protein that causes plaque buildup in Alzheimer's disease is the focus of a potential new ... Award-Winning Research Points Toward Targeted Alzheimer s Vaccine. Oral vaccine targets RAGE and amyloid by using body's immune ... FRONT PAGE Aging Health Alzheimer's - Mental Nutrition Medicare & Medicaid Politics Fitness Social Security Alerts Sex Health ... Read the latest news on Alzheimer's, Dementia & Mental Health. 'Unfortunately, all of the vaccines for Alzheimer's that have ...
  http://seniorjournal.com/NEWS/Alzheimers/2011/20110926-Award-Winning.htm
*  Neurology News in 2005: The Year in Review | Medpage Today
... including small positive studies of gene therapy for Alzheimer's and Parkinson's d ... A nasally administered therapeutic vaccine reduced amyloid plaques by 73% in mice with induced Alzheimer's (P. Because the ... Nasal Vaccine Clears Plaques in Mice with Induced Alzheimer's In November, researchers at Brown Medical School suggested that ... Alzheimer's. This year saw researchers struggling to find more effective therapies for Alzheimer's disease, with important ...
  https://www.medpagetoday.com/neurology/generalneurology/2400
*  Patent US5223482 - Recombinant Alzheimer's protease inhibitory amyloid protein and method of use - Google Patents
These sequences are used in producing or constructing recombinant β-amyloid core protein, β-amyloid-related proteins and ... proteins or immunogenic peptides derived therefrom can be used for cerebral fluid or serum protein diagnosis of Alzheimer's ... DNA sequences encoding β-amyloid-related proteins associated with Alzheimer's disease are disclosed. Also provided herein is a ... Amyloid-beta polypeptide vaccine. US20020119162 *. Feb 19, 2002. Aug 29, 2002. Nielsen Klaus Gregorius. Synthetic vaccine ...
  http://www.google.com/patents/US5223482?dq=oakley+5,387,949
*  Search results | ALZFORUM
... the first amyloid vaccine and passive immunotherapy for Alzheimer's, and other groundbreaking approaches ... ... Eric M. Reiman on Dale Schenk, 59, Pioneer of Alzheimer's Immunotherapy. COMMENT Dale was a true pioneer in Alzheimer's ... COMMENT Allen was a founding adviser to the Arizona Alzheimer's Disease Core Center and Alzheimer's Consortium. He was a ... COMMENT In 2011, a task force for NIA and the Alzheimer's Association conceptualized Alzheimer's disease as a progressive ...
  https://www.alzforum.org/search?fq%5B%5D=entity_type:comment&fq%5B%5D=tm_comment_authors_full_name:Reiman,%20Eric%20M.
*  Evolutionary Psychiatry: November 2010
It would be interesting to see that immune globulin helps Alzheimer's when beta amyloid vaccine doesn't seem to do much at all ... Certain spirochetes have been found in the amyloid plaques in the brains of patients with Alzheimer's (once again - there's the ... any infectious disease theory of Alzheimer's also has to explain why having ApoE4 makes you more likely to get Alzheimer's. ... I've dedicated many posts to Alzheimer's, which is a reflection of the amount of research out there. And for today's post, I'm ...
  http://evolutionarypsychiatry.blogspot.com/2010/11/
*  The Past, Present and Future of Vaccines | SpringerLink
Panza, F. et al. (2014), Amyloid-Directed Monoclonal Antibodies for the Treatment of Alzheimer's Disease: The Point Of No ... Evans CF, Davtyan H, Petrushina I et al., Epitope-based DNA vaccine for Alzheimer's disease: translational study in macaques. ... Grignolio A. (2018) The Past, Present and Future of Vaccines. In: Vaccines: Are they Worth a Shot?. Copernicus, Cham. * DOI ... Vesikari T. et al. (2011), Oil-In-Water Emulsion Adjuvant with Influenza Vaccine in Young Children, "The New England Journal of ...
  https://link.springer.com/chapter/10.1007%2F978-3-319-68106-1_5
*  Vaccine trial for Alzheimer's clears key hurdle
A vaccine which revives a promising but long-abandoned path to thwart Alzheimer's disease has cleared a key safety hurdle in ... In Alzheimer's, one of the enemies is a toxic protein called amyloid beta peptide, which accumulates in plaques in the brain, ... Vaccine trial for Alzheimer's clears key hurdle. June 7, 2012 A vaccine which revives a promising but long-abandoned path to ... Alzheimer's vaccine cures memory of mice. December 9, 2011 (Medical Xpress) -- A vaccine that slows the progression of ...
  https://medicalxpress.com/news/2012-06-vaccine-trial-alzheimer-key-hurdle.html
*  Journal of Alzheimer's Disease - Volume 33, issue s1 - Journals - IOS Press
Keywords: Alzheimer's disease pathogenesis, amyloid-β oligomers, animal models, biomarkers, cellular mechanisms, vaccines ... Keywords: Alzheimer's disease, amyloid-β, amyloid cascade hypothesis, asymptomatic, biomarkers, connectivity, CSF, default mode ... Abstract: Amyloid-β (Aβ) deposition in the brain is one of the key pathological features of Alzheimer's disease (AD). Neither ... Neurovascular Defects and Faulty Amyloid-β Vascular Clearance in Alzheimer's Disease Authors: Sagare, Abhay P. , Bell, Robert D ...
  https://content.iospress.com/journals/journal-of-alzheimers-disease/33/s1
*  Vaccine for Alzheimer's diseas ( Researchers developing a vaccine agains...)
When Alzheimer's mice are vaccinated with beta-amyloid peptide the...,Vaccine,for,Alzheimer's,diseas,medicine,medical news ... The vaccines reduces the build-up of protein deposits in mouse bra...Nearly one in ten people over the age of 65 suffers the ... Researchers developing a vaccine against Alzheimer's disease have show... ... Vaccine for Alzheimer's diseas. Researchers developing a vaccine against Alzheimer's disease have show...The vaccines reduces ...
  http://www.bio-medicine.org/medicine-news/Vaccine-for-Alzheimer-u2019s-diseas-120-1/
*  New exams for Alzheimer's disease in the works | The Olympian
Treatment will come in the form of a vaccine. ... a test that will identify the biological markers of Alzheimer's ... tau and beta-amyloid proteins - in cerebrospinal fluid. (Amyloid is the dangerous brain plaque found in Alzheimer's patients, ... "In the vaccine trials, we are asking: Are there ways to immunize people to prevent accumulation of amyloid plaque?" says Dr. ... Others are experimenting with passive vaccines designed to directly remove beta-amyloid from the brain. The most promising, AAB ...
  http://www.theolympian.com/living/article25232320.html